Life ScienceCompany
Sanofi has acquired 30 companies, including 9 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 14 assets.
Sanofi’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2018, when it sold Zentiva Group a.s. to Advent International for $2.2B. Sanofi has acquired in 8 different US states, and 11 countries. The Company’s most targeted sectors include life science (66%) and medical products (16%).
Join Mergr and gain access to Sanofi’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity40
- M&A Buy Activity26
- M&A Sell Activity14
- Total Sectors Invested 5
- Total Countries Invested 11
- M&A Buy/Sell Connections 27
- M&A Advisors 6
Unlimited Searches
